Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Current Obesity Reports Springer Nature Link Clinical trials of subcutaneous tirzepatide, retatrutide, and Download Scientific Diagram retatrutide and cagrilintide 15mg 5mg Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased Anti Obesity Medications in Patients With Heart Failure: Current Evidence and Practical Guidance Circulation: Heart Failure